Paper Details

  1. Home
  2. Paper Details

Nanotechnology for breast cancer therapy.

Author: CristofanilliMassimo, DecuzziPaolo, FerrariMauro, RobertsonFredika M, SakamotoJason H, TanakaTakemi, TasciottiEnnio

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This paper discusses the potential of nanotechnology in breast cancer treatment. While significant progress has been made with pegylated liposomal doxorubicin and albumin nanoparticulate paclitaxel, breast cancer morbidity and mortality remain high. Nanotechnology offers solutions to address the challenges of disease heterogeneity, multiple pathways, resistance, and side effects by improving drug delivery. The paper highlights the need for collaboration between breast cancer specialists and nanotechnologists to develop more effective therapeutic strategies.
Paper Details　
Original Abstract of the Article :
Breast cancer is the field of medicine with the greatest presence of nanotechnological therapeutic agents in the clinic. A pegylated form of liposomally encapsulated doxorubicin is routinely used for treatment against metastatic cancer, and albumin nanoparticulate chaperones of paclitaxel were appro...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s10544-008-9209-0

データ提供：米国国立医学図書館（NLM）

Harnessing Nanotechnology to Conquer Breast Cancer

Breast cancer is a formidable foe, claiming countless lives each year. This research explores the potential of nanotechnology as a powerful weapon in the fight against this devastating disease. The authors highlight the remarkable progress in the field, emphasizing the clinical use of nanotechnological therapeutic agents, such as liposomally encapsulated doxorubicin and albumin nanoparticulate chaperones of paclitaxel. They argue that nanotechnology offers a promising solution to the challenges posed by the extreme biological diversity of breast cancer, the multiple pathways that drive disease progression, and the limitations of current treatment strategies.

Nanotechnology: A New Era in Breast Cancer Treatment

The study reveals that nanotechnology has already made significant contributions to breast cancer therapy, with drugs like liposomally encapsulated doxorubicin and albumin nanoparticulate chaperones of paclitaxel showing substantial clinical benefits. These advancements demonstrate the potential of nanotechnology to revolutionize breast cancer treatment, offering new hope for patients seeking a cure.

The Promise of a Personalized Approach to Breast Cancer

The study underscores the potential of nanotechnology to address the unique challenges posed by breast cancer. Its ability to target specific cells and deliver drugs more effectively could lead to more personalized and effective treatments. This personalized approach holds the promise of improving treatment outcomes and reducing the side effects associated with traditional therapies.

Dr.Camel's Conclusion

Imagine a desert landscape, vast and unforgiving. Breast cancer is like a relentless sandstorm, threatening to consume everything in its path. Nanotechnology is like a beacon of hope, offering new tools to fight this disease. This research is a testament to the power of scientific innovation in the fight against cancer, reminding us that even the most formidable foes can be overcome with the right tools and strategies.

Date :
  1. Date Completed 2009-04-14
  2. Date Revised 2009-02-05
Further Info :

Pubmed ID

18663578

DOI: Digital Object Identifier

10.1007/s10544-008-9209-0

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.